- Home
- GLDG vs STTK Comparison
GLDG vs STTK Comparison
Compare GLDG & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDG
- STTK
- Stock Information
- Founded
- GLDG 2009
- STTK 2016
- Country
- GLDG Canada
- STTK United States
- Employees
- GLDG N/A
- STTK N/A
- Industry
- GLDG Precious Metals
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- GLDG Basic Materials
- STTK Health Care
- Exchange
- GLDG Nasdaq
- STTK Nasdaq
- Market Cap
- GLDG 159.6M
- STTK 83.8M
- IPO Year
- GLDG N/A
- STTK 2020
- Fundamental
- Price
- GLDG $1.20
- STTK $2.14
- Analyst Decision
- GLDG Strong Buy
- STTK Hold
- Analyst Count
- GLDG 1
- STTK 6
- Target Price
- GLDG $3.25
- STTK $2.67
- AVG Volume (30 Days)
- GLDG 1.8M
- STTK 1.5M
- Earning Date
- GLDG 10-10-2025
- STTK 11-13-2025
- Dividend Yield
- GLDG N/A
- STTK N/A
- EPS Growth
- GLDG N/A
- STTK N/A
- EPS
- GLDG N/A
- STTK N/A
- Revenue
- GLDG N/A
- STTK $2,997,000.00
- Revenue This Year
- GLDG N/A
- STTK N/A
- Revenue Next Year
- GLDG N/A
- STTK N/A
- P/E Ratio
- GLDG N/A
- STTK N/A
- Revenue Growth
- GLDG N/A
- STTK N/A
- 52 Week Low
- GLDG $0.71
- STTK $0.69
- 52 Week High
- GLDG $1.34
- STTK $3.95
- Technical
- Relative Strength Index (RSI)
- GLDG 68.10
- STTK 58.93
- Support Level
- GLDG $1.14
- STTK N/A
- Resistance Level
- GLDG $1.30
- STTK $2.01
- Average True Range (ATR)
- GLDG 0.07
- STTK 0.21
- MACD
- GLDG 0.02
- STTK 0.01
- Stochastic Oscillator
- GLDG 68.89
- STTK 99.53
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.